![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its imaging products and agents assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its agents are typically non-radioactive compounds that are used in ... Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its imaging products and agents assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its agents are typically non-radioactive compounds that are used in diagnostic procedures, such as cardiac ultrasounds, or echocardiograms, x-ray imaging used by physicians to progress the clarity of the diagnostic image. Its portfolio of imaging products includes medical radiopharmaceuticals such as DEFINITY, TechneLite, Xenon Xe 133 Gas, Cardiolite, and Neurolite. Its revenue is generated from the sales of diagnostic imaging agents to wholesalers, distributors radiopharmacy and directly to hospitals and clinics predominantly in the United States. Show more
BEDFORD, Mass., July 17, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the βCompanyβ) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on...
BEDFORD, Mass., July 15, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc.Β (βLantheusβ) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find...
BEDFORD, Mass., July 10, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (βLantheusβ) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find...
BEDFORD, Mass., July 08, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc.Β (βLantheusβ) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find...
BEDFORD, Mass., June 27, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc.Β (βLantheusβ) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -8.89 | -7.21883881445 | 123.15 | 126.8899 | 113.66 | 1373194 | 119.29457822 | CS |
4 | 35.16 | 44.4500632111 | 79.1 | 126.8899 | 76.0967 | 1563911 | 107.46189335 | CS |
12 | 48.45 | 73.6210302386 | 65.81 | 126.8899 | 65.76 | 1120874 | 91.5491877 | CS |
26 | 60.87 | 114.010114254 | 53.39 | 126.8899 | 50.2 | 1036198 | 74.96490527 | CS |
52 | 26.98 | 30.9120073327 | 87.28 | 126.8899 | 50.2 | 1094652 | 70.54244858 | CS |
156 | 88.19 | 338.281549674 | 26.07 | 126.8899 | 22.2 | 1007533 | 65.74494766 | CS |
260 | 85.76 | 300.912280702 | 28.5 | 126.8899 | 8.67 | 810533 | 53.13636264 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions